electronRx

Building Regulatory-Ready Digital Insights for Respiratory Care.

[electronRx @electron_Rx]

Geography, mobility and deprivation limit access to respiratory care.

Smartphone-based testing needs no extra hardware, bringing COPD and asthma monitoring within reach of more patients.

Wider access supports earlier detection and fairer care.

#COPD #Respiratory #DigitalHealth

[electronRx @electron_Rx]

Geography, mobility and deprivation limit access to respiratory care.

Smartphone-based testing needs no extra hardware, bringing COPD and asthma monitoring within reach of underserved patients.

Wider access supports earlier detection and fairer care.

#COPD #Asthma #Respiratory

[electronRx @electron_Rx]

Respiratory disease affects 500M+ people worldwide.

electronRx's white paper and clinical studies support continuous digital measurement across COPD, asthma, ILD and pulmonary hypertension

Continuous disease needs more than occasional care.

#Respiratory #Health #ChronicDisease

[electronRx @electron_Rx]

electronRx's continuous-monitoring work spans the UK and Japan, testing early detection of respiratory deterioration across different populations and care models.

For COPD, international evidence strengthens confidence in local clinical impact.

#COPD #Respiratory #DigitalHealth

[electronRx @electron_Rx]

Chronic disease drives most healthcare activity but care remains episodic.

Continuous heart and lung monitoring reveals changes between appointments, helping care teams deliver connected care.

Continuous insight supports clinical expertise.

#Respiratory #Health #DigitalHealth

[electronRx @electron_Rx]

COPD and asthma can deteriorate between appointments, where current models see least.

Continuous measurement gives an early deterioration signal to act on.

See the decline sooner, act sooner, and keep more patients out of hospital now.

#COPD #Asthma #Health #RemoteMonitoring

[electronRx @electron_Rx]

ILD monitoring relies on imaging, clinic visits, and symptoms, yet respiratory function can change quietly between assessments.

For ADCs, this creates a safety blind spot.

Continuous data can reveal changes.

New Blog 👉 https://t.co/cI2Nju8Pvm

#ILD #DigitalHealth #Respiratory

[electronRx @electron_Rx]

electronRx pairs a smartphone-based measurement, returning respiratory results in sixty seconds

Applied across populations rather than a clinic, becoming a way to manage chronic disease burden at the level of health systems

https://t.co/PSWhtQP0Ei

#Health #Respiratory #MedTech

[electronRx @electron_Rx]

We’re delighted to be attending ERS Congress 2026! 🇪🇺

We’re looking forward to joining fellow professionals from across the respiratory community at ERS Congress 2026.

If you’re attending, we’d be delighted to connect and arrange a time to meet.

#ERS #Barcelona #Respiratory

[electronRx @electron_Rx]

Predicting and limiting treatment toxicity is becoming a key focus.

ILD shows the opportunity: identifying patients sooner and detecting early lung injury could enable precise decisions.

Safer treatment journeys define progress.

https://t.co/IqIENZKeij

#ADCs #ILD #Respiratory

[electronRx @electron_Rx]

Respiratory services are among the most pressured in the NHS.

Giving clinicians an early, objective read on which patients are deteriorating lets scarce capacity follow genuine risk rather than the calendar.

Read More 👉 https://t.co/3JlhhHgyih

#COPD #Asthma #NHS

[electronRx @electron_Rx]

electronRxs respiratory measurement has been studied against clinical reference standards, with findings being prepared for peer-reviewed publications

Peer review is the discipline that separates a credible platform from a confident claim

https://t.co/ZvCOyvXaRl

#Respiratory

[electronRx @electron_Rx]

International evidence strengthens the case that early detection of deterioration travels, and that a smartphone-based platform can support exacerbation management wherever patients live.

https://t.co/rGJ0tAtev7

#COPD #Respiratory #Health

[electronRx @electron_Rx]

Adherence is where most monitoring quietly fails.

A sixty-second smartphone test that patients can do at home changes the adherence equation, and consistent measurement is what makes early detection of an exacerbation possible.

https://t.co/BKquHl8PDO

#Asthma #COPD

[electronRx @electron_Rx]

Smartphone measurements give that visibility without new hardware, turning the home into a monitored setting and a rising deterioration score into an early prompt to act.

Read Our New Blog 👉 https://t.co/UsqVVyjeUM

#VirtualWards #RemoteMonitoring #DigitalHealth

[electronRx @electron_Rx]

In drug-induced ILD, the challenge is not awareness of the risk but visibility of what happens between assessments

Continuous respiratory measurement is designed to close that gap, observing change over time rather than an occasional scan

https://t.co/TFwwEIuefA

#ILD #Health

[electronRx @electron_Rx]

One platform, one smartphone, a widening clinical reach

electronRx captures biomechanical and physiological signals to return respiratory function in sixty seconds backed by 644 subjects across multiple investigations

https://t.co/Cb9swj4f8H

#DigitalHealth #Respiratory #Health

[electronRx @electron_Rx]

Claims are easy in digital health; evidence is harder.

electronRx's approach has been built on clinical investigation rather than assertion, with 644 subjects and a programme of further studies now underway across the UK and Japan.

#Respiratory #DigitalBiomarkers #Health

[electronRx @electron_Rx]

The cost of waiting is measured in both pounds and outcomes.

Continuous monitoring shifts the economics by catching deterioration early enough to manage it in the community rather than the acute ward.

Read Our New Blog 👉 https://t.co/gwb6MPEitJ

#COPD #Asthma #Health

[electronRx @electron_Rx]

For clinicians and patients, tolerability matters just as much, because treatment-related toxicity drives dose reductions and hospitalisation.

ILD is among the most consequential of these risks, and its early signs are non-specific and easy to miss.

#ADCs #ILD #Health